Sepsis - to Reduce Mortality in the Intensive Care Unit
8
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
Adjunctive Fludrocortisone in Septic Shock
Phoenixin-14 Downregulation in Sepsis
Evaluating the Accuracy of Multiple Blood Tests to Diagnose Sepsis in Adult Burn Patients
ROTEM in Sepsis Trauma Outcome in Intensive Care
Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis
Comparative Effectiveness of Oxiris Hemofilters Versus Conventional Hemofilters in Septic Patients
Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality